The Asco Post

Opinion

Time to Move Forward With Lung ScreeningJune 25, 2014, Volume 5, Issue 10

Start with the most lethal cancer globally—lung cancer—for which standard approaches result in a modest 5-year survival. Then consider the results from the National Lung Screening Trial (NLST), suggesting in a well done randomized study that significant mortality reduction does occur with low-dos...

Read More

Consent Is Informed and Shared, But Is It Compassionate?December 15, 2013, Volume 4, Issue 20

A 72-year-old, obese male patient and a poor operative candidate is diagnosed with esophageal carcinoma. He has multiple comorbidities and a past history of colon carcinoma. His staging workup, which included a colonoscopy, revealed recurrent colon carcinoma. Thus, we have a patient who we initia...

Read More

Standardizing the Interpretation of PET Scans: An INR EquivalentNovember 15, 2013, Volume 4, Issue 18

Since its introduction, the positron-emission tomography (PET) scan has shown great potential to improve our ability to care for patients with lymphoma. By demonstrating which masses seen on a computed tomography (CT) scan represent viable tumor, and by identifying viable tumor in places that wer...

Read More

A Great Privilege to Die Beneath an Open Sky September 15, 2013, Volume 4, Issue 15

It was 1:00 AM, and my beeping pager awakened me. When you’re a surgical oncologist, you know that a page from your chief resident at this hour of the morning usually means someone may need to go to the operating room. And, yes, it was the chief resident about a patient in crisis. Except in this ...

Read More

The Oncologist as Author: On Guiding Patients Through Cancer September 15, 2013, Volume 4, Issue 15

When Tumor Is the Rumor and Cancer Is the Answer is the guidebook to cancer that Kevin P. Ryan, MD, FACP, COL, USAF (ret) wished his patients had during his 30 years of practicing oncology. The book, recently published by AuthorHouse, is an authoritative, inspiring, and even philosophical guide f...

Read More

Oncologists Speak Out Against the High Cost of Cancer Drugs August 15, 2013, Volume 4, Issue 13

That the United States spends twice as much on health care than other industrialized countries—about $2.8 trillion in 2012—without reaping appreciably better outcomes1 is not news. The topic has been dissected on the front pages of leading newspapers for years and was the subject of the entire fe...

Read More

Disparities in Cancer Care: How A Deep South Community Overcame Them May 15, 2013, Volume 4, Issue 8

Racial inequities were a daily observation for Edward E. Partridge, MD, growing up in Alabama during the civil rights era. When he became a physician, he saw that these disparities extended into his own field, gynecologic oncology. He decided to do something about it. Dr. Partridge recently discu...

Read More

Debt and the Oncology Fellow May 15, 2013, Volume 4, Issue 8

Despite today’s challenging economy, health care is one field that offers vast career opportunities. Oncology, with the impending workforce shortage, is especially eager for bright young doctors to join its ranks. But the rising costs of medical school can be a deterrent, leading the best and bri...

Read More

Sexual Health after Cancer: Communicating with Your Patients April 15, 2013, Volume 4, Issue 6

Studies show virtually all cancer survivors will experience some form of sexual dysfunction following a cancer diagnosis and treatment. Yet few cancer survivors seek help for physical problems they may be experiencing, such as vaginal dryness, dyspareunia, chemically induced menopause, reduced li...

Read More

Another Perspective on Accountable Care OrganizationsApril 15, 2013, Volume 4, Issue 6

I read with great interest Dr. Richard Boxer’s editorial on accountable care organizations in the January 15 issue of The ASCO Post. Much of what he says is unfortunately true. There are several points that I would like to make, however. First of all, Dr. Boxer states that the “principle that de...

Read More

To Scan or Not to Scan for Colon Cancer Recurrence?July 1, 2012, Volume 3, Issue 10

Over the past 2 decades, we have seen a substantial increase in the 5-year survival of patients with stage II and III colon cancer, marking an evolving oncologic success story. However, in the postoperative setting, the value of regular CT screening to monitor for recurrence has been greeted wi...

Read More

Important Lessons for Oncology from the Front Lines of the AIDS PandemicNovember 15, 2011, Volume 2, Issue 17

On June 5, 1981, the CDC issued a warning about a rare type of pneumonia discovered among a small group of young gay men in Los Angeles, later determined to be AIDS-related, ushering in the HIV/AIDS epidemic. Early on, AIDS-related malignancies brought the oncology community into this formidable ...

Read More
/
More on Twitter